• Our latest events
    Therapy Watch to present “real-world” patient data at ACR conference in Washington on November 11-16

    We are delighted to have been chosen to present two posters at this year’s ACR conference in Washington on November  11-16. The posters, which are entitled, ‘A Real World View of Rheumatoid Arthritis Patients Treated with Advanced Therapies’ and ‘Patient Adherence with Biologic Therapy in RA’ are authored by Research Director Laurent Chanroux. Using patient data taken from our Therapy Watch and Living With surveys…

    read more »
    Research Partnership attends the PMRC conference 2016 in Berlin

    On 20 – 21 October 2016, Research Partnership attended and exhibited at the Pharma Market Research Conference in Berlin, Germany The conference was very well attended, with around 100 delegates participating over the course of the two days. Our representatives, Director Sue Rees and Associate Director Kate Hanson, were attending and exhibiting at the event, but managed to see a few of the presentations. Sue…

    read more »
    24th United European Gastroenterology Week, Vienna, Austria

    15 - 19 October 2016

    read more »
  • Our latest news
    Research Partnership has published a new Living with Chronic Pain market report for 2016

    Research Partnership has published a new Living with Chronic Pain market report for 2016. Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans. Living with Chronic Pain is a quantitative study conducted online amongst 390 US patients with diabetic neuropathic pain, chronic lower back pain, cancer pain and headache/migraine pain. At least 60% of the patients surveyed are…

    read more »
    Research Partnership has published a new Living with Ulcerative Colitis (UC) market report for 2016.

    Ulcerative Colitis (UC) is a progressive and debilitating disease which affects between 2.5 to 3 million people in Europe. Living with UC is a quantitative study conducted online amongst 325 patients, including both adult and paediatric patients diagnosed with ulcerative colitis in 5 EU markets (France, Germany, Italy, Spain and the UK).  The report is intended to help pharmaceutical companies with products in this disease…

    read more »
    Therapy Watch expands its oncology portfolio

    This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio which covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer (PCa), Renal Cell Carcinoma. About 80% of head and neck cancer is due to the use…

    read more »

Healthcare consulting

We don’t just conduct market research, we provide healthcare consulting by applying the therapeutic and market knowledge gained over years of managing global projects across developed and emerging markets for major pharmaceutical brands. We don’t just use off-the-shelf methods, we apply customised research solutions to your business problem. We don’t just deliver insights, we give you recommendations and help you take strategic action to build your brand. We don’t just present you with a nice-looking report, we tell the story uncovered in the research and help you share understanding with your key stakeholders. Our sister organisation Access Partnership complements our capabilities, providing market access, reimbursement and pricing strategy consulting.